Patent ID: 6713071
Filing Date: 2004-03-30
Classification: A61K,C07K,G01N

Abstract:
A vaccine against Actinobacillus pleuropneumoniae, comprising an immunologically effective amount of(a) a substantially purified polypeptide comprising the amino acid sequence of amino acid residue 20 to amino acid residue 172 of SEQ ID NO:2, (b) a substantially purified polypeptide comprising the amino acid sequence of amino acid residue 22 to amino acid residue 215 of SEQ ID NO:4, (c) a substantially purified polypeptide comprising the amino acid sequence of amino acid residue 28 to amino acid residue 258 of SEQ ID NO:6, (d) a substantially purified polypeptide comprising the amino acid sequence of amino acid residue 20 to amino acid residue 364 of SEQ ID NO:8, and (e) a substantially purified polypeptide comprising the amino acid sequence of amino acid residue 20 to amino acid residue 369 of SEQ ID NO:10; an adjuvant; and a veterinarily acceptable carrier or diluent.